What does this research mean for the field?

Established phenotypic clustering of Type 2 diabetes into subgroups shows limited separation, substantial instability over time, and provides similar prognostic performance for mortality, CVD, and CKD compared to standard clinical variables. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This study aims to evaluate the phenotypic clustering of type 2 diabetes into specific subgroups and assess their prognostic implications.

June 7, 2026Diabetes

T2D phenotypic clustering shows no prognostic advantage over standard clinical variables for mortality, CVD, and CKD.

Q: What is the clinical evidence from this study?

Study design: Cohort. Population: Type 2 Diabetes (n=1333). Intervention: Phenotypic clustering models (discrete subgroup membership or continuous probabilities) vs. Original clinical variables. Primary outcome: Discrimination for mortality, CVD, and CKD (C-indices: mortality 0.696-0.700; CVD 0.642-0.647; CKD 0.669-0.677).

View Full Paper

Ask AI

Bookmark

Why the study?

Phenotypic clustering into T2D subgroups may capture disease heterogeneity, but its performance and stability in diverse populations remain uncertain.

Does phenotypic clustering of T2D improve prognostic discrimination for mortality, CVD, and CKD compared to standard clinical variables?

Population

871 prevalent and 462 incident T2D cases in the Multiethnic Study of Atherosclerosis

Comparison

Discrete subgroup membership vs continuous subgroup probabilities vs original clinical variables

Design

Cohort study

Follow-up

18 years

Key result

Phenotypic clustering of Type 2 Diabetes showed substantial subgroup transitions and similar prognostic performance for mortality, CVD, and CKD compared with standard clinical variables.

Authors

LOLANA OLSON FHFang‐Chi Hsu KSKIRK SMITH

Discussion

Member takes

Overview

Does not improve T2D prognostication over standard variables; leaves open whether dynamic reassessment adds value.

Key Points

This study aims to evaluate the phenotypic clustering of type 2 diabetes into specific subgroups and assess their prognostic implications.
Utilized established k-means clustering models in 871 prevalent and 462 incident T2D cases.
Analyzed data across four exams (2000-2007) including age at onset, BMI, HbA1c, HOMA2-IR, and HOMA2-β.
Evaluated mortality and disease outcomes using three models in 869 prevalent cases with long-term follow-up.
MARD was the most common subgroup (50% prevalent; 64% incident), whereas SIDD was rare in incident cases (0.6%).
Cumulative incidence of mortality, CVD, and CKD were 38%, 32%, and 50%, with modest discrimination performance across models.
Transition rates were notable, with SIDD instability showing 21-42% retention across exams and higher mortality rates (4-10%).

Study Design

Type

Cohort (n=1,333)

Multicenter

Yes

Structured PICO

Does phenotypic clustering of T2D improve prognostic discrimination for mortality, CVD, and CKD compared to standard clinical variables?

Population

1,333 prevalent and incident Type 2 Diabetes cases from the Multiethnic Study of Atherosclerosis followed for up to 18 years.

Exposure

Established k-means clustering models for T2D subgroups (MARD, MOD, SIDD, SIRD)

Comparator

Original clinical variables (age at onset, BMI, HbA1c, HOMA2-IR, and HOMA2-β)

Outcome

Discrimination for mortality, CVD, and CKDhard clinical

Main Result

Effect estimate: C-indices: mortality 0.696-0.700; CVD 0.642-0.647; CKD 0.669-0.677

Established T2D phenotypic clustering does not improve prognostic discrimination for mortality, CVD, or CKD over standard clinical variables in a multiethnic cohort.

Limitations

Did not account for diabetes duration and progression

Cite This Study

OLSON et al. (2026) conducted a cohort in Type 2 Diabetes (n=1,333). Phenotypic clustering models (discrete subgroup membership or continuous probabilities) vs. Original clinical variables was evaluated on Discrimination for mortality, CVD, and CKD (C-indices: mortality 0.696-0.700; CVD 0.642-0.647; CKD 0.669-0.677). Phenotypic clustering of Type 2 Diabetes showed substantial subgroup transitions and similar prognostic performance for mortality, CVD, and CKD compared with standard clinical variables.

synapsesocial.com/papers/6a250cd27def13d035e1cfbd https://doi.org/10.2337/db26-2351-p

View Full Paper

Ask AI

Bookmark

June 7, 2026Diabetes

T2D phenotypic clustering shows no prognostic advantage over standard clinical variables for mortality, CVD, and CKD.

View Full Paper

Ask AI

Bookmark

Why the study?

Phenotypic clustering into T2D subgroups may capture disease heterogeneity, but its performance and stability in diverse populations remain uncertain.

Does phenotypic clustering of T2D improve prognostic discrimination for mortality, CVD, and CKD compared to standard clinical variables?

Population

871 prevalent and 462 incident T2D cases in the Multiethnic Study of Atherosclerosis

Comparison

Discrete subgroup membership vs continuous subgroup probabilities vs original clinical variables

Design

Cohort study

Follow-up

18 years

Key result

Phenotypic clustering of Type 2 Diabetes showed substantial subgroup transitions and similar prognostic performance for mortality, CVD, and CKD compared with standard clinical variables.

Authors

LOLANA OLSON FHFang‐Chi Hsu KSKIRK SMITH

Discussion

Member takes

Overview

Does not improve T2D prognostication over standard variables; leaves open whether dynamic reassessment adds value.

Key Points

This study aims to evaluate the phenotypic clustering of type 2 diabetes into specific subgroups and assess their prognostic implications.
Utilized established k-means clustering models in 871 prevalent and 462 incident T2D cases.
Analyzed data across four exams (2000-2007) including age at onset, BMI, HbA1c, HOMA2-IR, and HOMA2-β.
Evaluated mortality and disease outcomes using three models in 869 prevalent cases with long-term follow-up.
MARD was the most common subgroup (50% prevalent; 64% incident), whereas SIDD was rare in incident cases (0.6%).
Cumulative incidence of mortality, CVD, and CKD were 38%, 32%, and 50%, with modest discrimination performance across models.
Transition rates were notable, with SIDD instability showing 21-42% retention across exams and higher mortality rates (4-10%).

Study Design

Type

Cohort (n=1,333)

Multicenter

Yes

Structured PICO

Does phenotypic clustering of T2D improve prognostic discrimination for mortality, CVD, and CKD compared to standard clinical variables?

Population

1,333 prevalent and incident Type 2 Diabetes cases from the Multiethnic Study of Atherosclerosis followed for up to 18 years.

Exposure

Established k-means clustering models for T2D subgroups (MARD, MOD, SIDD, SIRD)

Comparator

Original clinical variables (age at onset, BMI, HbA1c, HOMA2-IR, and HOMA2-β)

Outcome

Discrimination for mortality, CVD, and CKDhard clinical

Main Result

Effect estimate: C-indices: mortality 0.696-0.700; CVD 0.642-0.647; CKD 0.669-0.677

Established T2D phenotypic clustering does not improve prognostic discrimination for mortality, CVD, or CKD over standard clinical variables in a multiethnic cohort.

Limitations

Did not account for diabetes duration and progression

Cite This Study

synapsesocial.com/papers/6a250cd27def13d035e1cfbd https://doi.org/10.2337/db26-2351-p

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark